tiprankstipranks
Alaunos Therapeutics Inc (TCRT)
:TCRT
US Market

Alaunos Therapeutics (TCRT) Financial Statements

Compare
675 Followers

Alaunos Therapeutics Financial Overview

Alaunos Therapeutics's market cap is currently $2.48M. The company's EPS TTM is $-7.356; its P/E ratio is ―; Alaunos Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 5.00K$ 2.92M$ 398.00K$ 0.00$ 0.00
Gross Profit$ -4.80M$ 163.00K$ -342.00K$ -1.13M$ -629.00K
Operating Income$ -34.27M$ -35.10M$ -77.55M$ -80.36M$ 2.26M
EBITDA$ -30.90M$ -31.82M$ -74.97M$ -78.85M$ -117.17M
Net Income$ -35.14M$ -37.60M$ -76.89M$ -78.85M$ -177.92M
Balance Sheet
Cash & Short-Term Investments$ 6.06M$ 39.06M$ 76.05M$ 115.07M$ 79.74M
Total Assets$ 8.26M$ 64.94M$ 94.86M$ 146.34M$ 109.11M
Total Debt$ 0.00$ 19.51M$ 29.36M$ 4.81M$ 2.35M
Net Debt$ -6.06M$ -19.55M$ -46.69M$ -110.25M$ -77.39M
Total Liabilities$ 1.96M$ 26.38M$ 36.81M$ 22.36M$ 109.11M
Stockholders' Equity$ 6.31M$ 38.55M$ 58.06M$ 123.98M$ 95.01M
Cash Flow
Free Cash Flow$ -30.34M$ -29.45M$ -64.79M$ -66.79M$ -41.14M
Operating Cash Flow$ -30.14M$ -29.23M$ -61.47M$ -57.01M$ -40.85M
Investing Cash Flow$ 1.35M$ -193.00K$ -3.32M$ -9.78M$ -284.00K
Financing Cash Flow$ -18.14M$ 6.37M$ 25.78M$ 102.12M$ 59.15M
Currency in USD

Alaunos Therapeutics Earnings and Revenue History

Alaunos Therapeutics Debt to Assets

Alaunos Therapeutics Cash Flow

Alaunos Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis